XLV Holdings Information

XLV is an equity ETF with a total of 62 individual holdings. The top holdings are Eli Lilly and Company stock at 13.50%, Johnson & Johnson at 11.23%, AbbVie at 7.24%, Merck & Co. at 5.63%, and UnitedHealth Group at 4.56%.

Total Holdings

Top 10 Percentage

58.99%

Asset Class

Equity

ETF Category

Health

Assets

37.77B

PE Ratio

22.89

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	13.50%	5,766,540
2	JNJ	Johnson & Johnson	11.23%	17,537,133
3	ABBV	AbbVie Inc.	7.24%	12,861,501
4	MRK	Merck & Co., Inc.	5.63%	18,061,996
5	UNH	UnitedHealth Group Incorporated	4.56%	6,591,912
6	AMGN	Amgen Inc.	3.61%	3,918,600
7	TMO	Thermo Fisher Scientific Inc.	3.47%	2,734,073
8	ABT	Abbott Laboratories	3.40%	12,654,022
9	GILD	Gilead Sciences, Inc.	3.25%	9,028,573
10	ISRG	Intuitive Surgical, Inc.	3.09%	2,584,328
11	PFE	Pfizer Inc.	3.03%	41,375,596
12	BMY	Bristol-Myers Squibb Company	2.34%	14,819,702
13	DHR	Danaher Corporation	2.22%	4,578,318
14	VRTX	Vertex Pharmaceuticals Incorporated	2.16%	1,848,362
15	SYK	Stryker Corporation	2.15%	2,506,383
16	MDT	Medtronic plc	2.11%	9,329,338
17	MCK	McKesson Corporation	2.02%	891,339
18	BSX	Boston Scientific Corporation	1.79%	10,792,113
19	CVS	CVS Health Corporation	1.71%	9,258,008
20	REGN	Regeneron Pharmaceuticals, Inc.	1.45%	733,541
21	HCA	HCA Healthcare, Inc.	1.41%	1,139,133
22	CI	The Cigna Group	1.31%	1,917,238
23	ELV	Elevance Health, Inc.	1.21%	1,606,111
24	COR	Cencora, Inc.	1.16%	1,415,612
25	ZTS	Zoetis Inc.	0.94%	3,071,910

Showing 25 of 62 holdings

Subscribe to see the full list

Activate Now

As of Mar 30, 2026